ITP: time to “bug off”?

por Cines, Douglas B.
Publicado em 2007

TMA: beware of complements

por Ricklin, Daniel, Cines, Douglas B.
Publicado em 2013

Bad (or good) things come in small packages

por Rauova, Lubica, Cines, Douglas B.
Publicado em 2013

The child with immune thrombocytopenia: to treat or not to treat, is that still the question?

por Cooper, Nichola, Cines, Douglas B.
Publicado no Haematologica (2019)

Diagnosing HIT: the need for speed

por Cuker, Adam, Cines, Douglas B.
Publicado no Blood (2020)

Thrombocytopenia in pregnancy

por Cines, Douglas B., Levine, Lisa D.
Publicado no Blood (2017)

Thrombocytopenia in pregnancy

por Cines, Douglas B., Levine, Lisa D.
Publicado no Hematology Am Soc Hematol Educ Program (2017)

Pathogenesis of Heparin-Induced Thrombocytopenia

por Arepally, Gowthami M., Cines, Douglas B.
Publicado no Transl Res (2020)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

por Cines, Douglas B., Bussel, James B.
Publicado no N Engl J Med (2021)

Pathobiology of Secondary Immune Thrombocytopenia

por Cines, Douglas B., Liebman, Howard, Stasi, Roberto
Publicado em 2009

Increased Fluidity of Human Platelet Membranes during Complement-Mediated Immune Platelet Injury

por Shattil, Sanford J., Cines, Douglas B., Schreiber, Alan D.
Publicado em 1978

Innate and adaptive immunity in ITP

por Lazarus, Alan H., Semple, John W., Cines, Douglas B.
Publicado em 2013

Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)

por Rauova, Lubica, Arepally, Gowthami, Poncz, Mortimer, Cines, Douglas B.
Publicado no Autoimmun Rev (2018)

Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT)

por Cai, Zheng, Zhu, Zhiqiang, Greene, Mark I, Cines, Douglas B
Publicado no Autoimmun Rev (2016)

Erythrocytes as carriers for drug delivery in blood transfusion and beyond

por Villa, Carlos H., Cines, Douglas B., Siegel, Don L., Muzykantov, Vladimir
Publicado no Transfus Med Rev (2016)

The ITP syndrome: pathogenic and clinical diversity

por Cines, Douglas B., Bussel, James B., Liebman, Howard A., Luning Prak, Eline T.
Publicado em 2009

tPA Contributes To Impairment of ATP and Ca Sensitive K Channel Mediated Cerebrovasodilation After Hypoxia/Ischemia Through Upregulation of ERK MAPK

por Armstead, William M., Riley, John, Cines., Douglas B., Higazi, Abd Al-Roof
Publicado em 2010

Combination Therapy With Glucagon And A Novel Plasminogen Activator Inhibitor-1 Derived Peptide Enhances Protection Against Impaired Cerebrovasodilation During Hypotension After Tr...

por Armstead, William M., Riley, John, Cines, Douglas B., Higazi, Abd Al-Roof
Publicado em 2012

PAI-1-Derived Peptide EEIIMD Prevents Hypoxia/Ischemia-Induced Aggravation of Endothelin- and Thromboxane-Induced Cerebrovasoconstriction

por Armstead, William M., Riley, John, Cines, Douglas B., Higazi, Abd Al-Roof
Publicado no Neurocrit Care (2014)

Inhibition of integrin α(V)β(3) prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia

por Kiessling, J. Willis, Cines, Douglas B., Higazi, Abd Al-Roof, Armstead, William M.
Publicado em 2009